Insider Transactions Reported by 15 Insiders of Alto Neuroscience, Inc.

Symbol
ANRO on NYSE
Location
Mountain View, CA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Alto Neuroscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew Dreyfus Director $96,920 13 May 2025
Christopher Nixon Cox Director $79,998 13 May 2025
Gwill York Director $61,999 13 May 2025
Husseini Manji Director $44,998 13 May 2025
Ramiro Sanchez Director $8,680 12 Aug 2025
Maha Radhakrishnan Director $5,040 08 Mar 2024
Po Yu (Jeff) Chen Director $4,882 06 Feb 2024
Amit Etkin PRESIDENT AND CEO, Director 03 Jul 2025
Alpha Wave Ventures GP, Ltd 10%+ Owner 01 Feb 2024
ALKEON CAPITAL MANAGEMENT LLC Director, Other* 01 Feb 2024
Apeiron Investment Group Ltd. Other* 06 Feb 2024
Alpha Wave Global, LP 10%+ Owner 06 Feb 2024
Adam Savitz Chief Medical Officer 03 Jul 2025
Jr. Michael Conick Hanley Chief Operating Officer 03 Jul 2025
Nicholas Conrad Smith Chief Financial Officer & Cbo 03 Jul 2025

Recent Insider Transactions by Companies or Individuals for Alto Neuroscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.